Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jansen

Showing results (671-680 of 703) with videos related to

Pageof 71
Sort By:
Plos One|June 15, 2016
Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome PatientsAnne M L Jansen, Marije A Geilenkirchen, Tom van Wezel, et al.
Rheumatology (Oxford, England)|June 9, 2017
Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitorsFemke B Lamers-Karnebeek, Jolanda J Luime, David F Ten Cate, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2026
Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery ProtocolFlorentine A J Verbeek, Miguel P Martinez, Ilse A C Spiekman, et al.
Arthritis Care & Research|March 26, 2016
Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold StandardNicola Dalbeth, H Ralph Schumacher, Jaap Fransen, et al.
Annals of the Rheumatic Diseases|October 30, 2014
Performance of classification criteria for gout in early and established diseaseWilliam J Taylor, Jaap Fransen, Nicola Dalbeth, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2024
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)Ilse A C Spiekman, Laurien J Zeverijn, Birgit S Geurts, et al.
Arthritis Care & Research|March 18, 2015
Study for Updated Gout Classification Criteria: Identification of Features to Classify GoutWilliam J Taylor, Jaap Fransen, Tim L Jansen, et al.
The Oncologist|December 18, 2023
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery ProtocolIlse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.
BMC Cancer|April 18, 2015
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trialNinos Ayez, Eric P van der Stok, Hans de Wilt, et al.
Pageof 71

Showing results (671-680 of 703) with videos related to

Sort By:
Pageof 71
Plos One|June 15, 2016
Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome PatientsAnne M L Jansen, Marije A Geilenkirchen, Tom van Wezel, et al.
Rheumatology (Oxford, England)|June 9, 2017
Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitorsFemke B Lamers-Karnebeek, Jolanda J Luime, David F Ten Cate, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2026
Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery ProtocolFlorentine A J Verbeek, Miguel P Martinez, Ilse A C Spiekman, et al.
Arthritis Care & Research|March 26, 2016
Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold StandardNicola Dalbeth, H Ralph Schumacher, Jaap Fransen, et al.
Annals of the Rheumatic Diseases|October 30, 2014
Performance of classification criteria for gout in early and established diseaseWilliam J Taylor, Jaap Fransen, Nicola Dalbeth, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2024
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)Ilse A C Spiekman, Laurien J Zeverijn, Birgit S Geurts, et al.
Arthritis Care & Research|March 18, 2015
Study for Updated Gout Classification Criteria: Identification of Features to Classify GoutWilliam J Taylor, Jaap Fransen, Tim L Jansen, et al.
The Oncologist|December 18, 2023
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery ProtocolIlse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.
BMC Cancer|April 18, 2015
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trialNinos Ayez, Eric P van der Stok, Hans de Wilt, et al.
Pageof 71